002365 永安藥業
按盤價 
14.090 -1.440 (-9.272%)
14.090 -1.440 (-9.272%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.176 | 1.130 | 3.106 | -0.615 | 7.228 |
| 總資產報酬率 ROA (%) | 1.960 | 0.998 | 2.653 | -0.516 | 5.959 |
| 投入資產回報率 ROIC (%) | 2.149 | 1.104 | 2.985 | -0.591 | 6.975 | 邊際利潤分析 |
| 銷售毛利率 (%) | 25.324 | 16.916 | 19.992 | 25.869 | 32.935 |
| 營業利潤率 (%) | 10.404 | 1.360 | 8.695 | 0.581 | 10.421 |
| 息稅前利潤/營業總收入 (%) | 11.365 | 1.247 | 7.319 | -0.087 | 9.034 |
| 淨利潤/營業總收入 (%) | 7.590 | 0.918 | 7.118 | -2.921 | 9.075 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.070 | -81.777 | 56.619 | 120.148 | 114.979 |
| 價值變動淨收益/利潤總額(%) | 10.181 | 298.389 | 62.250 | 616.874 | 3.425 |
| 營業外收支淨額/利潤總額(%) | -1.218 | -7.815 | -2.925 | 6.667 | 0.430 | 償債能力分析 |
| 流動比率 (X) | 5.248 | 5.652 | 4.827 | 4.717 | 4.192 |
| 速動比率 (X) | 4.794 | 5.207 | 4.450 | 4.446 | 3.668 |
| 資產負債率 (%) | 10.403 | 9.939 | 11.546 | 12.732 | 13.249 |
| 帶息債務/全部投入資本 (%) | 0.678 | 0.574 | 2.489 | 2.362 | 1.947 |
| 股東權益/帶息債務 (%) | 14,588.986 | 17,188.138 | 3,882.829 | 4,048.629 | 4,947.520 |
| 股東權益/負債合計 (%) | 863.720 | 908.463 | 748.007 | 663.854 | 628.128 |
| 利息保障倍數 (X) | 10.463 | -86.467 | -6.481 | 0.123 | -6.309 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.722 | 62.240 | 68.548 | 62.612 | 49.580 |
| 存貨周轉天數 (天) | 41.007 | 51.010 | 43.825 | 54.781 | 54.209 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 10/09/2026 12:45 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
